Leptin Promotes Angiogenesis via Pericyte STAT3 Pathway upon Intracerebral Hemorrhage

Cells. 2022 Sep 3;11(17):2755. doi: 10.3390/cells11172755.

Abstract

Angiogenesis is a vital endogenous brain self-repair processes for neurological recovery after intracerebral hemorrhage (ICH). Increasing evidence suggests that leptin potentiates angiogenesis and plays a beneficial role in stroke. However, the proangiogenic effect of leptin on ICH has not been adequately explored. Moreover, leptin triggers post-ICH angiogenesis through pericyte, an important component of forming new blood vessels, which remains unclear. Here, we reported that exogenous leptin infusion dose-dependent promoted vascular endothelial cells survival and proliferation at chronic stage of ICH mice. Additionally, leptin robustly ameliorated pericytes loss, enhanced pericytes proliferation and migration in ICH mice in vivo, and in ICH human brain microvascular pericytes (HBVPC) in vitro. Notably, we showed that pericytes-derived pro-angiogenic factors were responsible for enhancing the survival, proliferation and tube formation followed leptin treatment in human brain microvascular endothelial cells (HCMEC/D3)/HBVPC co-culture models. Importantly, considerable improvements in neurobehavioral function and hostile microenvironment were observed in leptin treatment ICH mice, indicating that better vascular functionality post ICH improves outcome. Mechanistically, this study unveiled that leptin boost post-ICH angiogenesis potentially through modulation of leptin receptor (leptinR)/Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathway in pericyte. Thus, leptin may be a lucrative option for the treatment of ICH.

Keywords: angiogenesis; intracerebral hemorrhage; leptin; neuroprotection; pericyte.

MeSH terms

  • Animals
  • Cerebral Hemorrhage* / metabolism
  • Endothelial Cells / metabolism
  • Humans
  • Leptin* / metabolism
  • Leptin* / pharmacology
  • Mice
  • Neovascularization, Physiologic*
  • Pericytes* / metabolism
  • STAT3 Transcription Factor / metabolism

Substances

  • Leptin
  • STAT3 Transcription Factor
  • STAT3 protein, human

Grants and funding

This work was supported by Grant Number 2020GXNSFAA259036 (to Rujia Liao) from the Fund of the Guangxi Natural Science Foundation, and the Guangxi Science and Technology Project (Grant Number Guike AD17129015 for Qinghua Li), and the Fund of Guangxi Research and Innovation Base for Basic and Clinical Application of Nerve Injury and Repair Project (Grant Number Guike ZY21195042 for Qinghua Li). Partial financial support was received from the Innovation Projects of Guangxi Graduate Education (YCSW2021246 for Zixian Zhou and YCSW2021254 for Wenjing Xiang). Partial financial support was received from the Plan Project of Guilin Scientific Research and Technology Development (2020011204-9 for Jungang Deng).